KeyBanc Initiates Coverage on Surgery Partners Inc(NASDAQ:SGRY). The shares have been rated Overweight. The rating by KeyBanc was issued on Jun 9, 2016.
In a different note, On Mar 14, 2016, Citigroup said it Maintains its rating on Surgery Partners Inc. In the research note, the firm Lowers the price-target to $25.00 per share. The shares have been rated ‘Buy’ by the firm.
Surgery Partners Inc(SGRY) last announced its earnings results on Mar 10, 2016 for Fiscal Year 2015 and Q4.Company reported revenue of $263.32M. Analysts had an estimated revenue of $246.70M. Earnings per share were $0.35. Analysts had estimated an EPS of $0.19.
Several Insider Transactions has been reported to the SEC. On Oct 23, 2015, Michael Thomas Doyle (Chief Executive Officer) sold 152,966 shares at $19.00 per share price.
Surgery Partners Inc. is a healthcare services company. The Company has differentiated outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. It operates through three segments: Surgical Facility Services segment Ancillary Services segment and Optical Services segment. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. The Ancillary Services Segment consists of a diagnostic laboratory a specialty pharmacy and multi-specialty physician practices. The Optical Services Segment consists of an optical laboratory an optical products group purchasing organization and a marketing business. As of August 17 2015 the Company owned or operated primarily in partnership with physicians a portfolio of 99 surgical facilities which consist of 94 ambulatory surgery centers (ASCs) and five surgical hospitals across 28 states.